On today's episode, we sit down with Ines Steffens, editor-in-chief of Eurosurveillance. Eurosurveillance is an open-access peer-reviewed scientific journal devoted to the epidemiology, surveillance, prevention and control of communicable diseases
Workshop highlights importance of social and behavioural sciences for Ukrainians living in Ukraine and neighbouring EU countries
A comprehensive two-day workshop held from 27 to 28 February in Krakow, Poland, shed light on the significance of social and behavioural sciences in combatting infectious diseases across Ukraine and adjacent EU countries.
ECDC completed a technical visit to Albania as part of its efforts to bolster the surveillance of communicable diseases in the country.
Resistance of Salmonella and Campylobacter bacteria to commonly used antimicrobials continues to be observed frequently in humans and animals, according to a report issued today by EFSA and ECDC.
The Multivariable Analysis Module, held from 19-23 February 2024, strengthened public health practitioners’ epidemiological data analysis skills.
The European Commission has launched a call for expression of interest aiming at the selection of the ECDC Advisory Forum members.
Countries that have decreased their consumption of antibiotics in both animals and humans have seen a reduction in antibiotic-resistant bacteria.
On 20 February 2024, the Management Board of ECDC nominated Dr Pamela Rendi-Wagner to be the next Director of ECDC for a five-year period (2024-2029).
During the 2023 West Nile virus transmission season, and as of 4 January 2024, 709 locally acquired human cases of West Nile virus infection, including 67 deaths, were reported by nine European Union countries.
In a move to bolster health preparedness in the EU`s neighbourhood regions and EU/EEA countries, ECDC organised a comprehensive training focusing on Epidemic Intelligence (EI) and Rapid Risk Assessment (RRA).
ECDC is gearing up for a dynamic year of training sessions, capacity-building, and collaboration with European Neighbourhood Policy (ENP) partner countries through its annual work programme for 2024.
Threat assessment brief: Measles on the rise in the EU/EEA - Considerations for public health response
In 2023, significant increases in the number of measles cases and outbreaks were observed globally, including in 40 of the 53 countries of the European region, and in at least ten EU/EEA countries.
Measles cases are expected to continue increasing in the EU/EEA in the coming months due to sub-optimal vaccination coverage for measles-containing vaccines (MCV) in a number of EU/EEA countries.
This special episode is hosted by James Ramsey, Head of the Communication Unit at the European Food Safety Authority (EFSA). He is joined by experts from ECDC, EFSA, the European Medicines Agency (EMA), the European Environment Agency (EEA), and the European Chemicals Agency (ECHA) to discuss the One Health perspective.
Risk Assessment: Emergence of hypervirulent Klebsiella pneumoniae ST23 carrying carbapenemase genes in EU/EEA countries - first update
This document assesses the risk associated with the dissemination of carbapenemase-producing hypervirulent Klebsiella pneumoniae (hvKp) of sequence type (ST) 23 and other STs in the European Union/European Economic Area (EU/EEA).
Since the most recent ECDC rapid risk assessment in 2021, the number of EU/EEA countries reporting hypervirulent Klebsiella pneumoniae (hvKp) sequence type (ST) 23 has increased from four to ten and the number of cases reported to ECDC by the countries, increased from 12 to 143.
The food-borne infections listeriosis and shigatoxigenic Escherichia coli are increasing in the EU/EEA and were in 2022 at levels higher than before the COVID-19 pandemic.
Every month ECDC provides detailed epidemiological overview of the worldwide transmission of chikungunya in its weekly threat report (Communicable Diseases Threat Report).
Every month ECDC provides detailed epidemiological overview of the worldwide transmission of dengue in its weekly threat report (Communicable Diseases Threat Report).
From 29 January to 2 February 2024, a team of experts from EC, ECDC, EFSA, Epiconcept and the Integrated Quality Laboratory Services (IQLS) will visit North Macedonia.